Bill Williams, President and CEO of BriaCell Therapeutics (CVE: BCT) tells Proactive Investors they believe they will literally "change the face of cancer immunotherapy."
Williams says BriaCell's approach is unique in that they have a personalized "off the shelf" approach to immunotherapy for cancer, targeting advanced breast cancer.
Meet Medusa Mining, Cora Gold, Group Eleven Resources Ltd., Harvest Minerals Ltd. and Crusader Resources Ltd at our event, London, 22 February 2018.Register here >>